OMIP-072
A 15-color panel for immunophenotypic identification, quantification, and characterization of leukemic stem cells in children with acute myeloid leukemia
Cytometry PART A, Volume 99, Issue 4, 382-387 (2021)
Marianne A. Petersen, Marie Bill, Carina A. Rosenberg
Description: This panel was designed to identify, quantify and phenotypically characterize putative leukemic stem cells (LSCs) in bone marrow (BM) samples from individual pediatric patients diagnosed with acute myeloid leukemia (AML). Based on an aberrant expression on immunophenotypically defined hematopoietic stem cells (HSCs), several antigens have been proposed as LSC markers in AML research, using healthy adult BM samples as reference material. Generally, these antigens have been evaluated individually in smaller panels (e.g. 8-color panels). This necessitates several tubes to characterize the LSC phenotype and compromises the ability to evaluate LSC heterogeneity. The present 15-color OMIP incorporates nine suggested LSC markers to comprehensively capture LSC immunophenotypes and to explore heterogenic marker-patterns within LSC populations in a single tube. Importantly, this single tube approach requires less input material, which is essential when sampling BM aspirates from pediatric patients where sample volumes often are sparse. As knowledge on normal expression levels of the included LSC markers in HSCs from hematologically healthy children are a prerequisite for labelling a phenotype as abnormal, we have evaluated the applicability of the panel on cryopreserved mononuclear cells (MNCs) isolated from BM samples from pediatric patients without hematological disorders as well as pediatric AML patients. The panel is optimized for cryopreserved BM MNCs, but could in principle, be utilized for LSC detection in any biological material containing human hematopoietic cells.
Species: Human
Tissue: Bone marrow
Cell Subset: B cell, B memory, Myeloid cells, Monocyte, Hsc, Mpp
Keyword: Acute myeloid leukemia (aml), Cryopreserved pbmc, Pediatric
Machine: BD LSR Fortessa
Panel details
Marker | Species | Clone | Fluorophore | Purpose | Co-expressions groups | Antigen Density |
---|---|---|---|---|---|---|
Bcl-2 | Human | bcl-2/100 | V450 | Increased expression level | AML, HSC | Med |
CD45 | Human | HI30 | Brilliant Violet 510 | Leukocytes | HSC, AML | Low |
TIM-3 | Human | 7D3 | Brilliant Violet 711 | Aberrance | AML | Low |
CD38 | Human | HIT2 | Brilliant Violet 786 | Stem/progenitor marker | AML, HSC | Med |
CD34 | Human | 581 | PerCP-Cy5.5 | Stem/progenitor marker | HSC, AML | Med |
CD45RA | Human | HI100 | PE-CF594 | Aberrance | AML | Low |
Dead Cell | All Species | Zombie Red | viability | |||
CD123 | Human | 7G3 | PE-Cy7 | Aberrance | AML | Med |
CD93 | Human | VIMD2 | APC | Aberrance | AML | Med |
CD25 | Human | 2A3 | APC-R700 | Aberrance | AML | Low |
CD117 | Human | 104D2 | Brilliant Violet 650 | Stem/progenitor marker | AML, HSC | Low |
CLEC12A | Human | HB3 | PE | Aberrance | AML | Low |
CD99 | Human | 3B2/TA8 | APC-Vio770 | Increased expression level | AML, HSC | Med |
IL-1 RAcP | Human | REA558 | Vio Bright FITC | Aberrance | AML | Low |
CD3 | Human | SK7 | PE-Cy5.5 | T cells | High |